C9orf72 and frontotemporal dementia: Furthermore, whereas human patients with C9ORF72-related FTD have reduced C9ORF72 levels in addition to the GGGGCC-repeat associated toxicities, endogenous C9ORF72 expression levels were not changed in our 66R overexpression model (Additional file 1: Figure S8).